Aconitase [32]
|
Catalyzes the isomerization of citrate to isocitrate |
NM_001098 |
18 |
CaSR [33]
|
Calcium-sensing receptor |
NM_000388 |
7 |
Citrate lyase [34]
|
Catalyzes the formation of acetyl-CoA from citrate |
NM_001096 |
29 |
Claudin 2 [35]
|
Tight junction protein, proximal tubule (PT) |
NM_001171092 |
2 |
Claudin 8 [35]
|
Tight junction protein, primarily distal nephron (DCT) |
NM_99328 |
1 |
Claudin 10 [36]
|
Tight junction protein, thick ascending limb (TAL) and intestine |
NM_001160100 |
5 |
Claudin 14 [37]
|
Tight junction protein, TAL |
NM_001146077 |
3 |
Claudin 16 [15]
|
Tight junction protein, TAL |
NM_006580 |
4 |
Claudin 19 [30]
|
Tight junction protein, TAL and DCT |
NM_001123395 |
5 |
CLCN5 [38]
|
Chloride channel 5, mutations cause Dent's disease |
NM_000084 |
15 |
CLCNKA [39]
|
Basolateral chloride channel expressed in TAL |
NM_001042704 |
20 |
CLCNKB [40]
|
Basolateral chloride channel expressed in TAL and DCT; mutation cause type III Bartter's syndrome |
NM_000085 |
20 |
FGF23 [41]
|
Fibroblast growth factor 23, phosphatonin |
NM_020638 |
3 |
GCMB [42]
|
Glial cell missing B, mutations cause familial isolated hypoparathyroidism |
NM_004752 |
5 |
Klotho [43]
|
Regulator of TRPV5 and FGF23 |
NM_004795 |
5 |
NHERF1 [44]
|
Hydrogen exchanger regulatory factor 1, mutations cause hypophosphatemia and nephrolithiasis |
NM_004252 |
6 |
NHERF2 [45]
|
Hydrogen exchanger regulatory factor 2, expressed like NHERF1 in PT |
NM_001130012 |
7 |
NKCC2 [46]
|
Na+-K−-2Cl−-cotransporter, mutations cause type 1 (neonatal) Bartter's syndrome |
NM_000220 |
27 |
PDZK1 [47]
|
Hydrogen exchanger regulatory factor 3, PT |
NM_002614 |
10 |
PIK3C2G |
Phosphoinositide-3-kinase, class 3, γ polypeptide |
NM_004570 |
32 |
PTH [48]
|
Parathyroid hormone |
NM_000315 |
3 |
PTHR [49]
|
Parathyroid hormone receptor 1 |
NM_000316 |
16 |
ROMK [50]
|
Renal outer medullary K+ channel, mutations cause type 2 Bartter's syndrome |
NM_000338 |
4 |
SLC12A3 [51]
|
Thiazide-sensitive Na+-Cl− cotransporter, mutation cause Gitelman's syndrome |
NM_000339 |
26 |
SLC13A2 [52]
|
Na+ citrate transporter NaC1 |
NM_001145975 |
12 |
SLC13A3 [53]
|
Na+ citrate transporter NaC2 |
NM_001193340 |
14 |
SLC25A1 [54]
|
Mitochondrial citrate transporter |
NM_005984 |
9 |
SLC26A1 [55]
|
Oxalate and sulfate anion transporter |
NM34425 |
4 |
SLC26A2 [56]
|
Oxalate and citrate exchanger |
NM_000112 |
2 |
SLC26A6 [57]
|
Oxalate and citrate exchanger |
NM_001040454 |
21 |
SLC34A1 [58]
|
Na+ phosphate co-transporter NaPi2A |
NM_003052 |
13 |
SLC34A3 [59]
|
Na+ phosphate co-transporter NaPi2C |
NM_001177316 |
13 |
SLC4A1 [60]
|
AE1 oxalate, mutations cause distal RTA |
NM_000342 |
20 |
SLC4A2 [61]
|
AE2 oxalate |
NM_003040 |
23 |
SLC4A3 [61]
|
AE3 oxalate |
NM_005070 |
23 |
TRPV5 [62]
|
Epithelial Ca2+ channel ECaC1 |
NM_019841 |
14 |
TRPV6 [63]
|
Epithelial Ca2+ channel ECaC2 |
NM_018646 |
15 |
UMOD [64]
|
Uromodulin |
NM_001008389 |
11 |
VDR [65]
|
Vitamin D receptor |
NM_000376 |
11 |
WNK4 [66]
|
Protein kinase, lysine deficient 4, mutations cause pseudohypoaldosteronism type 2 |
NM_032387 |
19 |